As R&D productivity declines and the age of blockbuster medicines reaches an end, the pharmaceutical industry is looking at ways to extend the profitable life of its products up to and beyond patent expiry.
10-Jun-2010 - MonoSol Rx and Applied Pharma Research have agreed to expand their working partnership to produce and market current prescription drug products in film form. This method of drug delivery has...
02-Jun-2010 - Indian API manufacturer Shasun Chemicals and Drugs turned a previous loss into profit for Q4 of this year as it seeks to make a dent in the biosimilar manufacturing sector.
01-Jun-2010 - Irish pharmaceutical company Elan says most potential investors are positive about proposal to spin-off drug delivery unit.
27-May-2010 - The EMA’s EudraVigilance post-authorisation module (EVPM) speeds detection of adverse drug reactions in some cases, according to a new study published in the journal Drug Safety
24-May-2010 - The Irish drugmaking sector well-place to proper despite “challenges” as the pharma industry evolves, according to PharmaChemical Ireland (PCI).
17-May-2010 - Eurand says Zenpap important to Q1 growth that recent FDA move provides the drug with significant potential for further expansion in cystic fibrosis (CF) market
17-May-2010 - 3M Drug Delivery Systems says new nasal MDI overcomes drip drawbacks using evaporating spray technology that can improve drug shelf-life.
04-May-2010 - Rheumatoid arthritis (RA) sufferers may soon have a new treatment delivery option thanks to US delivery specialist Antares Pharma’s partnership with Canadian injectables specialist Uman Pharma.
29-Apr-2010 - Pro-Tect (PRTT) says new technology patents could drive “revolution” in once-daily drug delivery for pain meds.
29-Apr-2010 - Pfizer will lose patent protection for Viagra in Brazil on June 20 after the Supreme Court (STJ) accepted recommendations by national intellectual property watchdog, the INPI.
21-Apr-2010 - Capacity at Blu Pharmaceutical’s recently acquired solid dosage production plant in Puerto Rico is set to expand considerable over the next three years according to company president Bill Luster.
20-Apr-2010 - Irish drugmaker Elan has once again raised the possibility of selling its delivery business, Elan Drug Technologies (EDT).
15-Apr-2010 - The US Food and Drug Administration (FDA) has issued Apotex with another warning letter about cGMP violations at two plants explaining the firm’s response to previous warnings “is inadequate and...
13-Apr-2010 - US drugmaker Javelin Pharmaceuticals says Hospira’s takeover bid is “superior” and terminates agreement with Myriad Pharmaceuticals (MPI).
12-Apr-2010 - US delivery specialist Penwest is to apply its Timerx tech to “complex” generic pharmaceuticals in a development and commercialisation pact with non-branded drugmaker Alvogen.
01-Apr-2010 - Sanofi-Aventis says French manufacturing operations will focus on vaccine and biotech drugs, unveiling €150m ($202m) plan to shift emphasis away from synthetic chemistry-based production.
29-Mar-2010 - Thermo Fisher Scientific will take charge of clinical trial material production at Eli Lilly’s research technology facility in Indianapolis as the pharmaceutical firm further reduces in-house capacity to cut costs....
25-Mar-2010 - Contract manufacturing organization (CMO) ScinoPharm says strong anticancer API sales and growing demand in Europe and Asia were key to record performance in 2009.
23-Mar-2010 - A Ghanian drugmaker will soon start producing generic pharmaceuticals for the West African market, according to investment group Emerging World Pharma.
18-Mar-2010 - US pharmaceutical and biotechnology firms spent a record $65bn (€48bn) on drug and vaccine R&D in 2009, says a new study by the Pharmaceutical Research and Manufacturers of America (PhRMA)...
18-Mar-2010 - Ireland must become an R&D hub as well as a drug manufacturing destination to prosper in the increasingly competitive global pharmaceutical market, says industry body PharmaChemical Ireland (PCI).
17-Mar-2010 - Prosonix’ new UMAX particle engineering technology is set to “revolutionise” the field of respiratory medicines, according to company CEO David Hipkiss.
16-Mar-2010 - US Food and Drug Administration (FDA) request for more Afrezza data is not safety related and will not require new clinical trials, says developer MannKind.
15-Mar-2010 - Drug researchers will have greater access to some top selling molecules, including currently patented compounds atorvastatin, sildenafil and celecoxib, thanks to Sigma Aldrich’s new bioactives deal with US drug major...
15-Mar-2010 - AstraZeneca targets global generics market in license and supply deal with Indian manufacturer Torrent Pharma.